Whitehawk Therapeutics, Inc. - WHWK
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Chief Medical Officer | A | A | 19,132.0 | 3.92 | 74,997.44 | 19,132.0 | View | |
| May 18, 2026 | See remarks | A | A | 51,020.0 | 3.92 | 199,998.4 | 448,126.0 | View | |
| May 18, 2026 | CHIEF FINANCIAL OFFICER | A | A | 38,265.0 | 3.92 | 149,998.8 | 333,489.0 | View | |
| May 18, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 51,021.0 | 3.92 | 200,002.32 | 569,643.0 | View | |
| May 18, 2026 | — | A | A | 2,072,756.0 | 8,124,996.24 | 16,841,134,706,437.44 | 2,072,756.0 | View | |
| May 18, 2026 | — | A | A | 255,102.0 | 3.92 | 999,999.84 | 274,796.0 | View | |
| May 14, 2026 | — | A | A | 6,377,714.0 | 3.9199 | 25,000,001.11 | 14,710,714.0 | View | |
| Apr 17, 2026 | CHIEF FINANCIAL OFFICER | S | D | 141,600.0 | 4.13 | 584,808.0 | 295,224.0 | View | |
| Apr 17, 2026 | CHIEF FINANCIAL OFFICER | S | D | 77,000.0 | 3.86 | 297,220.0 | 436,824.0 | View | |
| Apr 15, 2026 | See remarks | S | D | 92,460.0 | 3.64 | 336,554.4 | 397,106.0 | View | |
| Apr 15, 2026 | See remarks | S | D | 26,389.0 | 3.46 | 91,305.94 | 489,566.0 | View | |
| Apr 13, 2026 | See remarks | S | D | 6,596.0 | 3.43 | 22,624.28 | 515,955.0 | View | |
| Apr 13, 2026 | See remarks | S | D | 50,000.0 | 3.57 | 178,500.0 | 522,551.0 | View | |
| Apr 10, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 14,500.0 | 3.38 | 49,010.0 | 518,622.0 | View | |
| Apr 08, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 63,945.0 | 3.4 | 217,413.0 | 533,122.0 | View | |
| Apr 08, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 94,087.0 | 3.43 | 322,718.41 | 597,067.0 | View | |
| Apr 08, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 102,395.0 | 3.51 | 359,406.45 | 691,154.0 | View | |
| Apr 03, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 831,148.0 | 0.0 | 0.0 | 831,148.0 | View | |
| Apr 03, 2026 | CHIEF EXECUTIVE OFFICER | M | D | 775,828.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 03, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 26,858.0 | 3.48 | 93,465.84 | 793,549.0 | View | |
| Apr 03, 2026 | CHIEF EXECUTIVE OFFICER | M | A | 775,828.0 | — | — | 820,407.0 | View | |
| Apr 03, 2026 | CHIEF FINANCIAL OFFICER | A | A | 300,677.0 | 0.0 | 0.0 | 300,677.0 | View | |
| Apr 03, 2026 | CHIEF FINANCIAL OFFICER | M | D | 473,902.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 03, 2026 | CHIEF FINANCIAL OFFICER | M | A | 473,902.0 | — | — | 502,002.0 | View | |
| Apr 03, 2026 | See remarks | A | A | 250,058.0 | 0.0 | 0.0 | 250,058.0 | View | |
| Apr 03, 2026 | See remarks | M | D | 366,532.0 | 0.0 | 0.0 | 0.0 | View | |
| Apr 03, 2026 | See remarks | M | A | 366,532.0 | — | — | 572,551.0 | View | |
| Apr 03, 2026 | Chief Scientific Officer | A | A | 282,340.0 | 0.0 | 0.0 | 282,340.0 | View | |
| Apr 03, 2026 | Chief Medical Officer | A | A | 283,157.0 | 0.0 | 0.0 | 283,157.0 | View | |
| Mar 10, 2026 | CHIEF FINANCIAL OFFICER | M | D | 6,750.0 | 0.0 | 0.0 | 13,500.0 | View | |
| Mar 10, 2026 | CHIEF FINANCIAL OFFICER | S | D | 2,594.0 | 3.3096 | 8,585.1 | 28,100.0 | View | |
| Mar 10, 2026 | CHIEF FINANCIAL OFFICER | M | A | 6,750.0 | — | — | 30,694.0 | View | |
| Mar 10, 2026 | See remarks | M | D | 5,000.0 | 0.0 | 0.0 | 10,000.0 | View | |
| Mar 10, 2026 | See remarks | S | D | 1,834.0 | 3.3096 | 6,069.81 | 206,019.0 | View | |
| Mar 10, 2026 | See remarks | M | A | 5,000.0 | — | — | 207,853.0 | View | |
| Mar 10, 2026 | CHIEF EXECUTIVE OFFICER | M | D | 16,250.0 | 0.0 | 0.0 | 32,500.0 | View | |
| Mar 10, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 5,100.0 | 3.3096 | 16,878.96 | 44,579.0 | View | |
| Mar 10, 2026 | CHIEF EXECUTIVE OFFICER | M | A | 16,250.0 | — | — | 49,679.0 | View |